23 Feb uniQure
Posted at 19:43h
in
Jonathan Garen, Chief Business Officer
Lexington, MA
(NASDAQ: QURE)
uniQure is delivering on the promise of gene therapy single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and other severe genetic diseases.
www.uniqure.com